roximycin roxithromycin 300mg tablet blister pack
alphapharm pty ltd - roxithromycin, quantity: 300 mg - tablet, film coated - excipient ingredients: povidone; hyprolose; maize starch; poloxamer; colloidal anhydrous silica; purified talc; magnesium stearate; glucose; titanium dioxide; hypromellose; propylene glycol - adults: roxithromycin is indicated for the treatment of the following types of mild to moderately severe infections in adults caused by or likely to be caused by susceptible micro-organisms: upper respiratory tract infection: acute pharyngitis, tonsillitis, and sinusitis. lower respiratory tract infection: acute bronchitis and acute exacerbation of chronic bronchitis; community acquired pneumonia. skin and skin structure infections. non-gonococcal urethritis. children: roxithromycin 150 mg tablets are indicated for the treatment of the following mild to moderately severe infections in children weighing greater than 40 kg caused by or likely to be caused by susceptible micro-organisms: acute pharyngitis. acute tonsillitis. impetigo. appropriate culture and sensitivity tests should be performed when necessary to determine an organisms susceptibility and thus treatment suitability. therapy with roxithromycin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.
roximycin roxithromycin 150mg tablet blister pack
alphapharm pty ltd - roxithromycin, quantity: 150 mg - tablet, film coated - excipient ingredients: povidone; hyprolose; maize starch; poloxamer; colloidal anhydrous silica; purified talc; magnesium stearate; glucose; titanium dioxide; hypromellose; propylene glycol - adults: roxithromycin is indicated for the treatment of the following types of mild to moderately severe infections in adults caused by or likely to be caused by susceptible micro-organisms: upper respiratory tract infection: acute pharyngitis, tonsillitis, and sinusitis. lower respiratory tract infection: acute bronchitis and acute exacerbation of chronic bronchitis; community acquired pneumonia. skin and skin structure infections. non-gonococcal urethritis. children: roxithromycin 150 mg tablets are indicated for the treatment of the following mild to moderately severe infections in children weighing greater than 40 kg caused by or likely to be caused by susceptible micro-organisms: acute pharyngitis. acute tonsillitis. impetigo. appropriate culture and sensitivity tests should be performed when necessary to determine an organisms susceptibility and thus treatment suitability. therapy with roxithromycin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.
roximycin
alphapharm pty ltd - roxithromycin -
doxymycin®–100 capsules
cont_eth -
doxymycin®–100 tablets
cont_eth -
doxycin cap 100mg capsule
laboratoire riva inc. - doxycycline (doxycycline hyclate) - capsule - 100mg - doxycycline (doxycycline hyclate) 100mg - tetracyclines
doxycin tab 100mg tablet
laboratoire riva inc. - doxycycline (doxycycline hyclate) - tablet - 100mg - doxycycline (doxycycline hyclate) 100mg - tetracyclines
oxymycin 250mg tablets
dr reddy's laboratories (uk) ltd - oxytetracycline dihydrate - oral tablet - 250mg
oxymycine lp solution
zoetis canada inc - oxytetracycline hydrochloride - solution - 100mg - oxytetracycline hydrochloride 100mg - cattle; swine (pigs); sheep